InterWell closes $46 million round of equity funding, partners with 1,000 nephrologists
Click Here to Manage Email Alerts
InterWell Health closed a Series B, $46 million round of equity funding, partnering with more than 1,000 nephrologist investors and 55 nephrology practices across 31 states, according to a company press release.
“This offering expands our investor group of premier, visionary nephrology practices across the county,” Kim Sonnen, president of InterWell Health, said in the release. “We are poised to deliver extraordinary value to patients, providers and payers under value-based arrangements that support individuals living with chronic kidney disease.”
InterWell Health, founded in 2019, holds a network of more than 1,400 nephrologist participants and deploys an array of tools to identify and manage CKD through a partnership with Fresenius Medical Care North America.
“We partner with Fresenius Health Partners, the national leader in renal value-based care, to provide clinical workflows, care team support and robust data analytics that support our network physicians who direct the care of renal patients across the full continuum of care,” George Hart, MD, co-chief medical officer of InterWell Health, said in the release. “This combination sets us apart from the competition and positions us as best in class.”
Read more about
Click Here to Manage Email Alerts